INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,878,356 | +67.6% | 640,688 | 0.0% | 3.64% | +192.3% |
Q2 2023 | $7,086,009 | -17.6% | 640,688 | 0.0% | 1.24% | -30.0% |
Q1 2023 | $8,604,440 | +8.6% | 640,688 | 0.0% | 1.78% | +4.2% |
Q4 2022 | $7,925,311 | -11.3% | 640,688 | 0.0% | 1.71% | -18.1% |
Q3 2022 | $8,938,000 | +1.0% | 640,688 | 0.0% | 2.08% | -11.7% |
Q2 2022 | $8,848,000 | -15.1% | 640,688 | 0.0% | 2.36% | -10.1% |
Q1 2022 | $10,424,000 | -0.1% | 640,688 | 0.0% | 2.62% | +29.6% |
Q4 2021 | $10,437,000 | +9.7% | 640,688 | 0.0% | 2.02% | +35.6% |
Q3 2021 | $9,514,000 | -25.6% | 640,688 | 0.0% | 1.49% | -5.4% |
Q2 2021 | $12,795,000 | -13.5% | 640,688 | 0.0% | 1.58% | -42.1% |
Q1 2021 | $14,787,000 | +48.3% | 640,688 | +58.7% | 2.73% | +171.9% |
Q4 2020 | $9,971,000 | -40.4% | 403,688 | 0.0% | 1.00% | -78.5% |
Q3 2020 | $16,737,000 | -13.5% | 403,688 | 0.0% | 4.67% | -25.0% |
Q2 2020 | $19,341,000 | -23.9% | 403,688 | 0.0% | 6.22% | -57.5% |
Q1 2020 | $25,416,000 | -49.2% | 403,688 | 0.0% | 14.63% | -39.0% |
Q4 2019 | $50,025,000 | +86.7% | 403,688 | 0.0% | 23.97% | +31.5% |
Q3 2019 | $26,789,000 | +1.8% | 403,688 | +22.1% | 18.23% | +4.9% |
Q2 2019 | $26,314,000 | +11.5% | 330,697 | +56.8% | 17.38% | -6.2% |
Q1 2019 | $23,595,000 | -0.1% | 210,937 | -10.0% | 18.54% | -18.2% |
Q4 2018 | $23,623,000 | – | 234,375 | – | 22.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 234,375 | $23,623,000 | 22.67% |
Boxer Capital, LLC | 600,000 | $60,474,000 | 7.47% |
DLD Asset Management, LP | 834,600 | $84,136,000 | 5.77% |
GREAT POINT PARTNERS LLC | 200,000 | $20,158,000 | 2.55% |
BB BIOTECH AG | 575,719 | $58,027,000 | 1.86% |
Elk Creek Partners, LLC | 207,657 | $20,930,000 | 1.74% |
ALTRINSIC GLOBAL ADVISORS LLC | 277,944 | $28,014,000 | 1.34% |
Sarissa Capital Management LP | 54,000 | $5,442,000 | 1.21% |
QCM Cayman, Ltd. | 2,181 | $220,000 | 0.90% |
Opus Point Partners Management, LLC | 3,534 | $356,000 | 0.78% |